Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. (PTHS) Q1 2026 Earnings

PTHS·Reported May 14, 2026·Before market open

Pelthos Therapeutics Inc. reported Q1 2026 revenue of $10.9M, beat analyst consensus of $10.4M by $468.3K. Diluted EPS came in at $-3.09, beat the $-3.45 consensus by $0.36.

Revenue
$10.9Mbeat by $468.3K
Consensus: $10.4M
Diluted EPS
$-3.09beat by $0.36
Consensus: $-3.45
SEC

SEC Filings

Earnings release8-K · 0001919246-26-000071
Quarterly report10-Q · 0001919246-26-000070

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Pelthos Therapeutics Inc.'s Q1 2026 earnings report.

Pelthos Therapeutics Inc. (PTHS) reported Q1 2026 earnings on May 14, 2026 before market open.

Pelthos Therapeutics Inc. reported revenue of $10.9M and diluted EPS of $-3.09 for Q1 2026.

Revenue beat the consensus estimate of $10.4M by $468.3K. EPS beat the consensus estimate of $-3.45 by $0.36.

You can read the 8-K earnings release (0001919246-26-000071) and the 10-Q periodic report (0001919246-26-000070) directly on SEC EDGAR. The filing index links above go to sec.gov.